Why is RadNet, Inc. ?
- Poor long term growth as Operating profit has grown by an annual rate 38.99% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 6.12% signifying low profitability per unit of shareholders funds
- NET PROFIT(Q) At USD 11.42 MM has Grown at 355.43%
- INTEREST COVERAGE RATIO(Q) Highest at 424.69
- CASH AND EQV(HY) Highest at USD 1,637.87 MM
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 26.91%, its profits have fallen by -16.9%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 1.45% over the previous quarter.
How much should you hold?
- Overall Portfolio exposure to RadNet, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is RadNet, Inc. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
At USD 11.42 MM has Grown at 355.43%
Highest at 424.69
Highest at USD 1,637.87 MM
Lowest at 98.52 %
Highest at 8.71 times
Highest at USD 522.87 MM
Highest at USD 74.63 MM
Highest at USD 29.04 MM
At USD 1.5 MM has Grown at -87.27%
Grown by 12.25% (YoY
Here's what is working for RadNet, Inc.
Net Profit (USD MM)
Operating Profit to Interest
Pre-Tax Profit (USD MM)
Net Sales (USD MM)
Operating Profit (USD MM)
Pre-Tax Profit (USD MM)
Cash and Cash Equivalents
Debt-Equity Ratio
Debtors Turnover Ratio
Depreciation (USD MM)
Here's what is not working for RadNet, Inc.
Raw Material Cost as a percentage of Sales






